ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 57 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,099,110 | +105.9% | 147,306 | +104.7% | 0.00% | – |
| Q1 2024 | $1,019,475 | +181.9% | 71,946 | +200.2% | 0.00% | – |
| Q4 2023 | $361,662 | +30.5% | 23,967 | +31.0% | 0.00% | – |
| Q2 2023 | $277,032 | +9586.4% | 18,298 | -90.7% | 0.00% | -100.0% |
| Q1 2023 | $2,860 | +430.6% | 197,253 | +394.4% | 0.00% | – |
| Q4 2022 | $539 | -99.9% | 39,894 | -47.8% | 0.00% | -100.0% |
| Q2 2022 | $932,000 | +17.1% | 76,498 | +64.5% | 0.00% | – |
| Q4 2021 | $796,000 | – | 46,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $63,067,422 | 34.64% |
| 5AM Venture Management, LLC | 4,408,379 | $62,819,401 | 14.05% |
| StepStone Group LP | 761,277 | $10,848,197 | 2.20% |
| Baker Brothers Advisors | 4,865,819 | $69,337,921 | 0.89% |
| TCG Crossover Management, LLC | 584,955 | $8,335,609 | 0.87% |
| Nan Fung Group Holdings Ltd | 49,082 | $699,419 | 0.75% |
| Redmile Group, LLC | 560,971 | $7,993,837 | 0.48% |
| Corton Capital Inc. | 54,973 | $783,365 | 0.41% |
| CORNERCAP INVESTMENT COUNSEL INC | 13,014 | $185,450 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,496,250 | 0.03% |